{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:01:04Z","timestamp":1785412864338,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.psychres.2016.04.097","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T02:47:13Z","timestamp":1462070833000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine"],"prefix":"10.1016","volume":"241","author":[{"given":"Sean A.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia I.","family":"Rosebush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Anglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Mazurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2016.04.097_bib1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.60.12.1228","article-title":"Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected","volume":"60","author":"Agid","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib2","first-page":"93","article-title":"The \u201cdelayed onset\u201d of antipsychotic action: an idea whose time has come and gone","volume":"31","author":"Agid","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.psychres.2016.04.097_bib3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.euroneuro.2012.10.005","article-title":"Early prediction of clinical and functional outcome in schizophrenia","volume":"23","author":"Agid","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.04.097_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/schbul\/sbm134","article-title":"Clinical, functional, and economic ramifications of early nonresponse to antipsychotics in the naturalistic treatment of schizophrenia","volume":"34","author":"Ascher-Svanum","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.04.097_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-244X-11-152","article-title":"Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia","volume":"11","author":"Ascher-Svanum","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.04.097_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/YIC.0b013e328363aa33","article-title":"An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study","volume":"28","author":"Chou","year":"2013","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.04.097_bib8","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1176\/appi.ajp.160.11.2063","article-title":"Early prediction of antipsychotic response in schizophrenia","volume":"160","author":"Correll","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4088\/JCP.v60n1105","article-title":"Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder","volume":"60","author":"Emsley","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2011.02.011","article-title":"Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia","volume":"128","author":"Hatta","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0920-9964(99)00151-6","article-title":"Quality of life in schizophrenia: contributions of anxiety and depression","volume":"51","author":"Huppert","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2016.04.097_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jad.2010.10.026","article-title":"Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression","volume":"130","author":"Kemp","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2016.04.097_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2009.07.006","article-title":"Rapid antipsychotic response with ziprasidone predicts subsequent acute manic\/mixed episode remission","volume":"44","author":"Ketter","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.schres.2008.02.021","article-title":"Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia","volume":"102","author":"Kinon","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","article-title":"Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia","volume":"35","author":"Kinon","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2016.04.097_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.schbul.a033302","article-title":"Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations","volume":"24","author":"Lehman","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2016.04.097_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0447.2008.01308.x","article-title":"Definitions of response and remission in schizophrenia: recommendations for their use and their presentation","volume":"119","author":"Leucht","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2016.04.097_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S1461145710001380","article-title":"Evidence-based pharmacotherapy of schizophrenia","volume":"14","author":"Leucht","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.04.097_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0269881113517956","article-title":"Early improvement as a predictor of treatment response and remission in patients with schizophrenia: a pooled, post-hoc analysis from the asenapine development program","volume":"28","author":"Leucht","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.04.097_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1991.01810320063009","article-title":"Optimal dose of neuroleptic in acute schizophrenia: a controlled study of the neuroleptic threshold and higher haloperidol dose","volume":"48","author":"McEvoy","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0032-1331703","article-title":"Predicting a \u201ccombined treatment outcome\u201d in chronic schizophrenia: the role of demographics, symptomatology, functioning and subjective well-being","volume":"46","author":"Naber","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-244X-14-166","article-title":"Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia","volume":"14","author":"Naidu","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2014.10.028","article-title":"New approaches to psychiatric diagnostic classification","volume":"84","author":"Owen","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.psychres.2016.04.097_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2011.09.021","article-title":"Association between symptoms and quality of life in patients with schizophrenia: a pooled analysis of changes over time","volume":"133","author":"Priebe","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/15622975.2011.552633","article-title":"Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol","volume":"13","author":"Riedel","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.schres.2012.05.004","article-title":"Response trajectories in \u201creal-world\u201d naturalistically treated schizophrenia patients","volume":"139","author":"Schennach","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.euroneuro.2010.10.003","article-title":"Predictors of response and remission in the acute treatment of first-episode schizophrenia patients-is it all about early response?","volume":"21","author":"Schennach-Wolff","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.04.097_bib31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":"Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial","volume":"162","author":"Schooler","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.04.097_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.psychres.2010.11.017","article-title":"Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis","volume":"187","author":"Stauffer","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2016.04.097_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jad.2013.01.024","article-title":"Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program","volume":"150","author":"Szegedi","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2016.04.097_bib34","first-page":"869","article-title":"Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China","volume":"10","author":"Ye","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115304893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115304893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T15:52:53Z","timestamp":1536767573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178115304893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":34,"alternative-id":["S0165178115304893"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.04.097","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.04.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}